 This is a phase I trial to determine the maximum tolerated dose and recommended phase II dose of the combination therapy with Genexol-PM and Carboplatin and to evaluate the efficacy and safety of Genexol-PM when administered with Carboplatin in subjects with advanced ovarian cancer after debulking surgery. 